1-8 of 8
Kristina S. Yu
Close
Sort by
Journal Articles

Real-World Treatment Patterns and Clinical Outcomes with Brentuximab Vedotin or Other Standard Therapies in Patients with Previously Treated Cutaneous T-Cell Lymphoma (CTCL): A Retrospective Chart Review Study in the United States

Stefan K. Barta, Nicholas Liu, Maral DerSarkissian, Rose Chang, Mingchen Ye, Mei Sheng Duh, Andy Surinach, Michelle A. Fanale, Kristina S. Yu
Journal: Blood
Blood (2022) 140 (Supplement 1): 5167–5169.
https://doi.org/10.1182/blood-2022-162375
Published: 2022
Journal Articles

Economic Burden of Hematopoietic Cell Transplantation (HCT) Among Commercially Insured Patients with Hematological Malignancies in the United States (US)

Mayur Narkhede, Nicholas Liu, Andy Surinach, Michelle A. Fanale, Kristina S. Yu, Allison Winter
Journal: Blood
Blood (2022) 140 (Supplement 1): 10798–10800.
https://doi.org/10.1182/blood-2022-162603
Published: 2022
Journal Articles

Real-World Patient Characteristics, Treatment Patterns, and Outcomes in Patients with Stage III/IV Classic Hodgkin Lymphoma Treated with Frontline ABVD: A Retrospective Analysis Using a Real-World Database

Allison Winter, Nicholas Liu, Andy Surinach, Michelle A. Fanale, Kristina S. Yu, Mayur Narkhede
Journal: Blood
Blood (2022) 140 (Supplement 1): 8054–8055.
https://doi.org/10.1182/blood-2022-162556
Published: 2022
Journal Articles

An Oncology Simulation Model to Estimate 10-Year Progression-Free Survival and Stem Cell Transplantation for Frontline, Stage III or IV Classical Hodgkin Lymphoma Based on the 5-Year Update of the ECHELON-1 Trial: A United States Perspective

Tycel Phillips, Kristen Migliaccio-Walle, Kristina S. Yu, Brian Bloudek, Nicholas Liu, Michelle A. Fanale, John M. Burke
Journal: Blood
Blood (2021) 138 (Supplement 1): 2440.
https://doi.org/10.1182/blood-2021-147308
Published: 2021
Journal Articles

An Oncology Simulation Model to Estimate 10-Year Progression-Free Survival and Overall Survival Based on the 5-Year Update from the ECHELON-2 Trial in Frontline Patients with Peripheral T-Cell Lymphoma: A United States Perspective

John M. Burke, Kristina S. Yu, Uche Mordi, Brian Bloudek, Nicholas Liu, Michelle A. Fanale, Tycel Phillips
Journal: Blood
Blood (2021) 138 (Supplement 1): 2466.
https://doi.org/10.1182/blood-2021-148004
Published: 2021
Journal Articles

Classical Hodgkin Lymphoma; Real-World Observations from Physicians, Patients, and Caregivers on the Disease and Its Treatment (CONNECT): Physician First-Line Treatment Preferences for Stage III or IV Classical Hodgkin Lymphoma

Andrew M. Evens, Kristina S. Yu, Nicholas Liu, Andy Surinach, Katie Holmes, Carlos Flores, Supriya Kumar, Michelle A. Fanale, Darcy R. Flora, Susan K. Parsons
Journal: Blood
Blood (2021) 138 (Supplement 1): 2467.
https://doi.org/10.1182/blood-2021-152497
Published: 2021
Journal Articles

Classical Hodgkin Lymphoma; Real-World Observations from Physicians, Patients, and Caregivers on the Disease and Its Treatment (CONNECT): Observations of Physicians on Treatment and Interim PET-Adapted Regimens

Susan K. Parsons, Kristina S. Yu, Nicholas Liu, Supriya Kumar, Michelle A. Fanale, Katie Holmes, Carlos Flores, Andy Surinach, Darcy R. Flora, Andrew M. Evens
Journal: Blood
Blood (2021) 138 (Supplement 1): 1390.
https://doi.org/10.1182/blood-2021-151143
Published: 2021
Journal Articles

Classical Hodgkin Lymphoma; Real-World Observations from Physicians, Patients, and Caregivers on the Disease and Its Treatment (CONNECT)-a Cross-Sectional Survey of Patients with Stage III or IV Classical Hodgkin Lymphoma Compared By Age

Darcy R. Flora, Susan K. Parsons, Nicholas Liu, Kristina S. Yu, Katie Holmes, Carlos Flores, Michelle A. Fanale, Supriya Kumar, Andy Surinach, Rachel Byrd, Andrew M. Evens
Journal: Blood
Blood (2021) 138 (Supplement 1): 1966.
https://doi.org/10.1182/blood-2021-147354
Published: 2021